Jrsis Health Care Corp's ability to collect accounts receivable sequentially worsen to 10.39, pointing to a challenging and on top of that deteriorating business climate for the Healthcare Facilities industry. Jrsis Health Care's Accounts Receivable average collection period in the Sep 30 2024 quarter, has increased to 35 days, from 22 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 355 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 771 to 2572.

What is Receivable Turnover Ratio?
What is Jrsis Health Care Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

JRSS Receivables Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Receivable Change	25219.15 %	1124.04 %	3334.71 %	20597.73 %	-6.62 %
Y / Y Revenue Change	1543.12 %	1279.13 %	4.91 %	-	-
Receivable Turnover Ratio (TTM)	10.39	16.36	17.28	19.27	-
JRSS's Total Ranking	# 2572	# 771	# 0	# 0	#
Accounts Receivable average collection period days	35	22	21	19	-
Seq. Receivable Change	252.71 %	97.64 %	-87.04 %	27932.44 %	-82.95 %
Seq. Revenue Change	-62.68 %	19.38 %	-85.3 %	24998.02 %	-68.68 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 34
Healthcare Sector	# 356
Overall Market	# 2572

Receivable Turnover Ratio Statistics
High	Average	Low
675.99	147.85	3.03
(Mar 31 2020)		(Sep 30 2017)

JRSS Company Profile • Back to JRSS Efficiency Comparisons • Compare JRSS Receivables Turnover Ratio to its Competitors

Financial Statements
Jrsis Health Care's Accounts Receivable	$ 1 Millions	Visit JRSS's Balance sheet
Jrsis Health Care's Sales TTM	$ 5 Millions	Visit JRSS's Income Statement
Sources of JRSS's Revenues		Visit JRSS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
JRSS's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
JRSS's Growth Rates	JRSS's Roa	JRSS's Inventory Turnover Ratio	JRSS's Dividend Comparisons
JRSS's Profitability Ratios	JRSS's Roi	JRSS's Asset Turnover Ratio	JRSS's Dividend Growth
JRSS's Valuation Ratios	JRSS's Roe	JRSS's Financial Strength Ratios	JRSS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
Hookipa Pharma inc	17.97	$ 49.999 Millions	$ 2.782 Millions
Vireo Growth Inc.	17.70	$ 98.534 Millions	$ 5.568 Millions
Macrogenics Inc	17.38	$ 141.329 Millions	$ 8.132 Millions
Silence Therapeutics Plc	17.27	$ 43.010 Millions	$ 2.490 Millions
Innovage Holding Corp	17.01	$ 786.512 Millions	$ 46.249 Millions
Talkspace Inc	16.98	$ 179.853 Millions	$ 10.591 Millions
Scorpius Holdings inc	16.51	$ 10.044 Millions	$ 0.608 Millions
Arvinas Inc	16.48	$ 161.100 Millions	$ 9.775 Millions
Stablecoin Development Corporation	16.33	$ 11.199 Millions	$ 0.686 Millions
Bgm Group Ltd	16.31	$ 24.115 Millions	$ 1.478 Millions
Nexalin Technology Inc	16.24	$ 0.162 Millions	$ 0.010 Millions
Precipio inc	16.07	$ 17.411 Millions	$ 1.084 Millions
Sangamo Therapeutics Inc	15.97	$ 52.291 Millions	$ 3.274 Millions
Icu Medical Inc	14.80	$ 2,340.754 Millions	$ 158.125 Millions
Inmed Pharmaceuticals Inc	14.57	$ 4.284 Millions	$ 0.294 Millions
Biofrontera Inc	14.26	$ 61.432 Millions	$ 4.308 Millions
Valion Bio Inc	14.02	$ 0.957 Millions	$ 0.068 Millions
Mannkind Corporation	14.00	$ 267.200 Millions	$ 19.086 Millions
Qhslab Inc	13.69	$ 1.821 Millions	$ 0.133 Millions
Pluri Inc	13.36	$ 0.598 Millions	$ 0.045 Millions
Dih Holding Us Inc	13.13	$ 116.794 Millions	$ 8.898 Millions
Patterson Companies Inc	13.07	$ 6,555.862 Millions	$ 501.549 Millions
Chemed Corporation	12.84	$ 2,377.206 Millions	$ 185.072 Millions
International Stem Cell Corporation	12.65	$ 8.528 Millions	$ 0.674 Millions
Nrc Health	12.61	$ 144.154 Millions	$ 11.436 Millions
Poseida Therapeutics Inc	12.52	$ 150.858 Millions	$ 12.053 Millions
Petvivo Holdings Inc	12.46	$ 0.969 Millions	$ 0.078 Millions
American Oncology Network Inc	12.35	$ 2,211.480 Millions	$ 179.073 Millions
Utah Medical Products Inc	12.05	$ 43.301 Millions	$ 3.593 Millions
Lumos Pharma Inc	12.03	$ 2.205 Millions	$ 0.183 Millions

Date modified: 2026-08-29T17:25:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.